Hyperphagia
18
2
4
8
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
11.1%
2 terminated out of 18 trials
80.0%
-6.5% vs benchmark
17%
3 trials in Phase 3/4
63%
5 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (18)
Impact of Bright Light Therapy on Prader-Willi Syndrome
ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial
The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial
A Study of Setmelanotide in Patients With Prader-Willi Syndrome
Early Genetic Identification of Obesity
Exploratory Study of Sensory Profile and Coping Strategies in Eating Disorders
Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic Impact
Effect of Deep Propioceptive Stimulation in Prader-Willi Syndrome
Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome
fNIRS-based Neurofeedback Intervention for Cognitive Control Improvement in Emotional Overeating
Computerized Response Training Obesity Treatment
Fiber Intervention on Gut Microbiota in Children With Prader-Willi Syndrome
Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome
Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome
Effects of Noninvasive Brain Stimulation on Brain Activity and Appetite
The Impact of Snacks Which Vary Nutritionally in Their Satiating Potential on Measures of Appetite Control
Prader-Willi Syndrome and Appetite